1) Alvarenge PG, Mathis MA, Dominguez-Alves AC, et al:Clinical features of tic-related obsessive-compulsive disorder:Results from a large multicenter study. CNS Spectr 17:87-93, 2012
2) Bloch MH, Landerous-Weisenberger A, Kelmendi B, et al:A systematic review:Antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry 11:622-632, 2006
3) Cath DC, Spinhoven P, Landman AD, et al:Psychopathology and personality characteristics in relation to blood serotonin in Tourette's syndrome and obsessive compulsive disorder. J Psychopharmacol 15:111-119, 2001
4) Denys D:Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders. Psychiatr Clin N Am 29:553-584, 2006
5) Eichstedt JA, Arnold SL:Childhood-onset obsessive-compulsive disorder:A tic-related subtype of OCD? Clin Psychol Rev 21:137-157, 2001
6) Franklin ME, Harrison JP, Benavides KL:Obsessive-compulsive and tic-related disorders. Child Adolsc Psychiatric Clin N Am 21l:555-571, 2012
7) 福原綾子,三戸宏典,山西恭輔,他:トウレット障害を併存する強迫性障害の臨床像:第1報—併存による臨床像への影響に関する多角的検討.精神医学55:1063-1071, 2013
8) Gaze C, Keypley HO, Walkup JT:Co-occurring psychiatric disorders in children and adolescents with Tourette syndrome. J Child Neurol 21:657-664, 2006
9) Goodman W, Price L, Rasmussen SA, et al:The Yale-Brown Obsessive-Compulsive Scale, Ⅰ:development, use, and reliability. Arch Gen Psychiatry 46:1006-1011, 1989
10) Goodman W, Price L, Rasmussen SA, et al:The Yale-Brown Obsessive-Compulsive Scale, Ⅱ:Validity. Arch Gen Psychiatry 46:1012-1016, 1989
11) 金生由紀子:チック障害との関連によるOCDの検討.精神経誌111:810-815, 2009
12) Koran LM, Hanna GL, Hollander E, et al:Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry 164(suppl):1-56, 2007
13) Mataix-Cols D, Rauch SL, Manzo PA, et al:Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry 156:1409-1416, 1999
14) 松永寿人:強迫性障害.「神経症性障害の治療ガイドライン」精神科治療学26増刊号:「精神科治療学」編集委員会編.星和書店,pp56-67, 2011
15) 松永寿人,三戸宏典,山西恭輔:強迫性障害の診断-DSM-5の動向を含めて.臨床精神医学41:21-28, 2012
16) Mercadante MT, Rosario-Campos MC, Quarantini LC, et al:The neurobiological bases of obsessive-compulsive disorder and Tourette syndrome. J Pediatr 80(Suppl 2):S35-S44, 2004
17) Nestadt G, Riddle MA, Grados MA, et al:Obsessive-compulsive disorder:Subclassification based on comorbidity. Psychol Med 39:1491-1501, 2008
18) Paurfar M, Feigin A, Tang CC, et al:Abnormal metabolic brain networks in Tourette syndrome. Neurology 76:944-952, 2011
19) Singer HS:Tourette's syndrome:From behavior to biology. Lancet Neurol 4:149-159, 2005
20) Steeves TDL, Fox SH:Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome. Prog Brain Res 172:495-513, 2008
21) Stern E, Silbersweig DA, Chee KY, et al:A functional neuroanatomy of tics and Tourette syndrome. Arch Gen Psychiatry 57:741-748, 2000.
neurochemistry study with PET. Neuropsychopharmacology 7:1239-1251, 2008
23) 山西恭輔,荒井克純,林田和久,他:トウレット症候群を伴う強迫性障害の臨床像と治療—Blonanserineを用いたSSRI強化療法を中心に.精神科20:326-332, 2012